Faculty of Medicine
Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14
Browse
21 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, HCT-CI Predicts Survival in Autologous Stem Cell Transplantation in Myeloma Patients – Center Experience(Elsevier BV, 2018-09); ; ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hematologic Autoimmune Manifestation Secondary to Coronavirus Disease 19 Infection – A Single-Center Experience(Scientific Foundation SPIROSKI, 2021-09-11); ; ; <jats:p>Introduction: Since December 2019, multiple human cases of novel coronavirus infection were reported, representing with upper respiratory symptoms (influenza-like presentation). The virus was named the Severe acute respiratory system coronavirus 2 (SARS-COV-2). Studies have reported cases of patients with COVID-19 infection, including development of several autoimmune events that suggests that infection with SARS CoV-2 may be associated with initiation of autoimmune hematological autoimmune disorders. Aim: Review the hematological autoimmune phenomenon after infection with SARS-COV-2 in order to assist into the pathogenic mechanisms, clinical manifestations and treatment of this group of patients. Materials and methods: This is a retrospective study that includes 21 patients with autoimmune diseases like secondary immune thrombocytopenia (ITP), autoimmune hemolytic anemia( AIHA) and thrombotic thrombocytopenic purpura (TTP) that have emerged after COVID-19 infection. The patients were diagnosed and treated at the University Clinic of Hematology for a period of time from January 2020 to April 2021. Results: The most common hematologic autoimmune disorder was ITP in 13 cases (62%) followed by AIHA in 5 cases (24%) and TTP in 3 individuals (14%). The mean time of onset of the hematologic auto-immune presentations was 18,4 ± 10,3 days. The therapy of this conditions in patients with COVID-19 infection requires an individualized approach to achieve a precise balance between the risk of severe bleeding and of thromboembolic events. Conclusion: Causal relationship between COVID-19 infection and these autoimmune events still requires further studies. We should all have in mind the risk of development of hematologic autoimmune disorders in infected patients. </jats:p> - Some of the metrics are blocked by yourconsent settings
Item type:Publication, AML-327: Plasmacytoid Dendritic Cell Proliferation Associated with Acute Myeloid Leukemia: A Case Report(Elsevier BV, 2021-09); - Some of the metrics are blocked by yourconsent settings
Item type:Publication, AML-259: Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: Single Center Experience(Elsevier BV, 2020-09); ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, CLL-132: Mutational Status of IGVH in Correlation with Genetic Abnormalities of Patients with Chronic Lymphocytic Leukemia in Macedonia - A Single-Centre Experience(Elsevier BV, 2020-09); ; ; Ivanovski, Martin - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Multidrug Resistant Bacterial Isolates in Hematopoietic Stem Cell Recipients-Single Center Experience(Elsevier BV, 2019-09); ; ; ; Cadievski, Lazar - Some of the metrics are blocked by yourconsent settings
Item type:Publication, CLL-IPI for Macedonian Patients with Chronic Lymphocytic Leukemia(Elsevier BV, 2018-09) - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Biology Reforms Treatment in Diffuse Large B Cell Lymphoma-Single Centre Experience(Elsevier BV, 2018-09); - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Therapy Related Myeloid Neoplasia in Hodgkin Lymphoma after Autologous Stem Cell Transplantation (ASCT) – A Case Report(Elsevier BV, 2017-09); ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Хочкинова болест и бременост - приказ на случај(Македонско лекарско друштво = Macedonian medical association/Walter de Gruyter GmbH, 2014-08-01); ; ;
- «
- 1 (current)
- 2
- 3
- »